US · Healthcare

BioNxt Solutions Inc. (BNXTF)

Drug Manufacturers - Specialty & Generic

BioNxt Solutions Inc. (BNXTF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BNXTF

P/E ratio

18.00

BioNxt Solutions Inc. (BNXTF) — FAQ

What is BNXTF's P/E ratio?

The price-to-earnings (P/E) ratio for BioNxt Solutions Inc. (BNXTF) is 18.00 (data as of 2026-03-23).

Does BioNxt Solutions Inc. pay a dividend?

Dividend yield is not available in the current snapshot for BioNxt Solutions Inc. (BNXTF). Check the MyAverix Finance app for the latest dividend data.

What sector is BioNxt Solutions Inc. in?

BioNxt Solutions Inc. (BNXTF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is BNXTF listed on?

BNXTF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)